Leissinger Cindy Anne MD is categorized under Internal Medicine Doctors in New Orleans, LA and active since 2010.
Leissinger Cindy Anne MD was established in 2010, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Cindy Anne Leissinger at the company’s single location by writing to 1430 Tulane Avenue, New Orleans, Louisiana LA 70112 or by phoning (504) 588-5263. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Leissinger Cindy Anne MD |
| Contact Person: | Cindy Anne Leissinger |
| Address: | 1430 Tulane Avenue, New Orleans, Louisiana 70112 |
| Phone Number: | (504) 588-5263 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Leissinger Cindy Anne MD was started in 2010 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Cindy Anne Leissinger for inquiries that concern Leissinger Cindy Anne MD by calling the company number (504) 588-5263, as your correspondence is most welcome. Additionally, the physical location of the single location of Leissinger Cindy Anne MD can be found at the coordinates 29.955356,-90.076717 as well as the street address 1430 Tulane Avenue in New Orleans, Louisiana 70112.
For its online presence, you may visit Leissinger Cindy Anne MD’s website at and engage with its social media outlets through on Twitter and on Facebook.